Table 3 Summary and frequency (based on number of participants) of motivations for using CBHT
Motivations for using CBHT | # (%) of CBHT users |
|---|---|
Push away from conventional therapies | |
Fear and uncertainty about the safety of HT | 17 (80.9%) |
Distaste for conjugated estrogens, in particular | 10 (47.6%) |
Distrust of biomedicine and the pharmaceutical industry | 20 (95.2%) |
Push away from alternative therapies | |
Ineffective symptom management | 13 (61.9%) |
Pull toward CBHT | |
Effective symptom management | 16 (76.2%) |
Perception that CBHT is “safer” than conventional HT | 16 (76.2%) |
Desire for individualized treatment | 12 (57.1%) |
Enhanced clinical experience | 13 (61.9%) |